Altered calcium homeostasis in ALS as a target for therapy

References

• Engelhardt, JI, Siklos L, Appel SH. Altered calcium home- ostasis and ultrastructure in motoneurons of mice caused by passively transferred anti-motoneuronal IgG. J Neuropath. Exp Neurol 1997; 56: 21–39.
   PubMed Web of Science ®Google Scholar
• Siklos L, Engelhardt JI, Harati Y, Smith RG, Joo F, Appel SH. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann Neurol 1996; 39: 203–216.
   PubMed Web of Science ®Google Scholar
• Siklos L, Engelhardt JI, Alexianu ME, Gurney ME, Siddique T, Appel SH. Intracellular calcium parallels motoneuron degen- eration in SOD-1 mutant mice. J Neuropathol Exp Neurol 1998 June; 57: 571–587.
   PubMed Web of Science ®Google Scholar
• Rothstein JD, Tsai G, Kuncl RW, et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 1990; 28: 18–25.
   PubMed Web of Science ®Google Scholar
• Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992; 326: 1464–1468.
   PubMed Web of Science ®Google Scholar
• Lin CL, Bristol LA, Jin L, et al. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998; 20: 589–602.
   PubMed Web of Science ®Google Scholar
• Bowling AC, Schulz JB, Brown RH Jr, Beal MF. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993; 61: 2322–2325.
   PubMed Web of Science ®Google Scholar
• Yim MB, Kang J-H, Kwak H-S, Chock PB, Stadtman ER. A gain-of-function of an amyotrophic lateral sclerosis-associ- ated Cu, Zn superoxide dismutase mutant: an enhancement of free radical formation due to a decreased in Km for hydro- gen peroxide. Proc Natl Acad Sci USA 1996; 93: 5709–5714.
   PubMed Web of Science ®Google Scholar
• Dykens JA. Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated Ca2+ and Na+: implications for neurodegeneration. J Neurochem 1994; 63: 584–591.
   PubMed Web of Science ®Google Scholar
• Coyle JT, Putterfarcken P. Oxidative stress, glutamate and neurodegenerative disorders. Science 1993; 262: 689–696.
   PubMed Web of Science ®Google Scholar
• Tymianski M, Charlton MP, Carlen PL, Tator CH. Source specificity of early calcium neurotoxicity in cultured embry- onic spinal neurons. J Neurosci 1993; 13: 2085–2104.
   PubMed Web of Science ®Google Scholar
• Dugan LL, Sensi S, Canzoniero LMT, et al. Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J Neurosci 1995; 15: 6377–6388.
   PubMed Web of Science ®Google Scholar
• Carriedo SG, Yin HZ, Sensi S, Weiss JH. Rapid Ca2+ entry through Ca2+-permeable AMPA/Kainate channels triggers marked intracellular Ca2+ rises and consequent oxygen radical production. J Neurosci 1998; 18: 7727–7738.
   PubMed Web of Science ®Google Scholar
• Sheen VL, Dreyer EB, Macklis JD. Calcium-mediated neu- ronal degeneration following singlet oxygen production. Neuroreport 1992; 3: 705–708.
   Google Scholar
• Kakkar P, Mehrota S, Viaswanathan PN. Interrelation of active oxygen species, membrane damage and altered calcium functions. Mol Cell Biochem 1992; 111: 11–15.
   PubMed Web of Science ®Google Scholar
• Rothstein JD, Jin L, Dykes-Hoberg M, Kuncl RW. Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity. Proc Natl Acad Sci USA 1993; 90: 6591–6595.
   PubMed Web of Science ®Google Scholar
• Rothstein JD, Van Kammen M, Levy AI, Martin LJ, Kuncl RW. Selective loss of glial glutamate transporter (GLT-1) in amyotrophic lateral sclerosis. Ann Neurol 1995; 38: 73–84.
   PubMed Web of Science ®Google Scholar
• Rothstein JD, Dykes-Hoberg M, Pardo CA, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996; 16: 675–686.
   PubMed Web of Science ®Google Scholar
• Nagai M, Abe K, Okamoto K, Itoyama Y. Identification of alternative splicing forms of GLT-1 mRNA in the spinal cord of amyotrophic lateral sclerosis patients. Neurosci Lett 1998; 244: 165–168.
   PubMed Web of Science ®Google Scholar
• Pedersen WA, Fu W, Keller JN, et al. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol 1998; 44: 819–824.
   PubMed Web of Science ®Google Scholar
• Blanc EM, Keller JN, Fernandez S, Mattson MP. 4-hydroxy- nonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes. Glia 1998; 22: 149–160.
   PubMed Web of Science ®Google Scholar
• Carriedo SG, Yin HZ, Weiss JH. Motor neurons are selec- tively vulnerable to AMPA/kainate receptor-mediated injury in vitro. J Neurosci 1996; 16: 4069–4079.
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Williams TL, Slade JY, Eggett CJ, Ince PG. Low expression of GluR2 AMPA receptor subunit protein by human motor neurons. Neuroreport 1999; 10: 261–265.
   PubMed Web of Science ®Google Scholar
• Takuma H, Kwak S, Yoshizawa T, Kanazawa I. Reduction of GluR2 RNA editing, a molecular change that increases calcium influx through AMPA receptors, selective in the spinal ventral gray of patients with amyotrophic lateral scler- osis. Ann Neurol 1999; 46: 806–815.
   PubMed Web of Science ®Google Scholar
• Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral scler- osis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996; 347: 1425–1431.
   PubMed Web of Science ®Google Scholar
• Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1996; 39: 147–157.
   PubMed Web of Science ®Google Scholar
• Cleveland DW. From Charcot to SOD1: mechanisms of selective motor neuron death in ALS. Neuron 1999; 24: 515–520.
   PubMed Web of Science ®Google Scholar
• Borchelt DR, Lee MK, Slunt HS, et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 1994; 91: 8292–8296.
   PubMed Web of Science ®Google Scholar
• Reaume AG, Elliott JL, Hoffman EK, et al. Motor neurons in Cu/Zn superoxide dismutase - different mice develop nor- mally but exhibit enhanced cell death after axonal injury. Nat Genet 1996; 13: 43–47.
   PubMed Web of Science ®Google Scholar
• Ferrante RJ, Browne SE, Shinobu LA, et al. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J Neurochem 1997; 69: 2064–2074.
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Ince PG, Falkous G, Mantle D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann Neurol 1995; 38: 691–695
   PubMed Web of Science ®Google Scholar
• Smith R G, Henry KY, Mattson MP, Appel SH. Presence of 4- hydroxynonenal in the cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Ann Neurol 1998; 44: 696–699.
   Google Scholar
• Keller JN, Mattson MP. Roles of lipid peroxidation in modula- tion of cellular signaling pathways, cell dysfunction, and death in the nervous system. Rev Neurosci 1998; 9: 105–116.
   PubMed Web of Science ®Google Scholar
• Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RH Jr. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann Neurol 1997; 42: 644–654.
   PubMed Web of Science ®Google Scholar
• Aguirre T, Van Den Bosch L, et al. Increased sensitivity of fibroblasts from amyotrophic lateral sclerosis patients to oxidative stress. Ann Neurol 1998; 43: 452–457.
   PubMed Web of Science ®Google Scholar
• Mithal NP, Radunovic A, Figlewicz DA, McMillan TJ, Leigh PN. Cells from individuals with SOD-1 associated familial amyotrophic lateral sclerosis do not have an increased sus- ceptibility to radiation-induced free radical production or DNA damage. J Neurol Sci 1999; 164: 89–92.
   Google Scholar
• Przedborski S, Donaldson D, Jakowec M, Kish SJ, Guttman M, Rosoklija G, Hays AP. Brain superoxide dismutase, cata- lase, and glutathione peroxidase activities in amyotrophic lateral sclerosis. Ann Neurol 1996; 39: 158–165.
   PubMed Web of Science ®Google Scholar
• Ince PG, Shaw PJ, Candy JM, et al. Iron, selenium and glu- tathione peroxidase activity are elevated in sporadic motor neuron disease. Neurosci Lett 1994; 182: 87–90.
   PubMed Web of Science ®Google Scholar
• Fujita K, Yamauchi M, Shibayama K, Ando M, Honda M, Nagata Y. Decreased cytochrome c oxidase activity but unchanged superoxide dismutase and glutathione peroxi- dase activities in the spinal cords of patients with amy- otrophic lateral sclerosis. J Neurosci Res 1996; 45: 276–281.
   PubMed Web of Science ®Google Scholar
• Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 8: 623–634.
   Google Scholar
• Lipton SA, Choi YB, Pan ZH, et al. A redox-based mecha- nism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature 1993; 364: 626–632.
   PubMed Web of Science ®Google Scholar
• Orrenius S, McConkey DJ, Bellomo G, Nicotera P. Role of Ca2+ in toxic cell killing. Trends Pharmacol Sci 1989; 10: 281–285.
   PubMed Web of Science ®Google Scholar
• Heizmann CW, Braun K. Changes in Ca(2+)-binding proteins in human neurodegenerative disorders. Trends Neurosci 1992; 15: 259–264.
   PubMed Web of Science ®Google Scholar
• Colom LV, Alexianu ME, Mosier DR, Smith RG, Appel SH. Amyotrophic lateral sclerosis immunoglobulins increase intracellular calcium in a motoneuron cell line. Exp Neurol 1997; 146: 354–360.
   PubMed Web of Science ®Google Scholar
• Mosier DR, Baldelli P, Delbono O, et al. Amyotrophic lateral sclerosis immunoglobulins increase Ca2+currents in a motoneuron cell line. Ann Neurol 1995; 37: 102–109.
   Google Scholar
• Engelhardt JI, Siklos L, Komuves L, Smith RG, Appel SH. Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons. Synapse 1995; 20: 185–199.
   PubMed Web of Science ®Google Scholar
• Siklos L, Engelhardt JI, Adalbert R., Appel SH. Calcium-con- taining endosomes at oculomotor terminals in animal models of ALS. NeuroReport 1999; 10: 2539–2545.
   Google Scholar
• Bolanos JP, Almeida A, Stewart V et al. Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and impli- cations for neurodegenerative diseases. J Neurochem 1997; 68: 2227–2240.
   Google Scholar
• Sasaki S, Maruyama S, Yamane K, Sakuma H, Takeishi M. Ultrastructure of swollen proximal axons of anterior horn neurons in motor neuron disease. J Neurol Sci 1990; 97: 233–240.
   PubMed Web of Science ®Google Scholar
• Wiedemann FR, Winkler K, Kuznetsov AV, et al. Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis. J Neurol Sci 1998; 156: 65–72.
   PubMed Web of Science ®Google Scholar
• Nakano Y, Hirayama K, Terao K. Hepatic ultrastructural changes and liver dysfunction in amyotrophic lateral scler- osis. Arch Neurol 1987; 44: 103–106.
   PubMed Web of Science ®Google Scholar
• Wong PC, Pardo CA, Borchelt DR, Lee MK, Copeland NG, Jenkins NA, Sisodia SS, Cleveland DW, Price DL. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995; 14: 1105–1116.
   PubMed Web of Science ®Google Scholar
• Dal Canto MC, Gurney ME. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 1994; 145: 1271–1279.
   PubMed Web of Science ®Google Scholar
• Carri MT, Ferri A, Battistoni A, et al. Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett 1997; 414: 365–368.
   PubMed Web of Science ®Google Scholar
• Swerdlow RH, Parks JK, Cassarino DS, et al. Mitochondria in sporadic amyotrophic lateral sclerosis. Exp Neurol 1998; 153: 135–142.
   PubMed Web of Science ®Google Scholar
• Borthwick GH, Johnson MA, Ince PG, Shaw PJ, Turnbull DM. Mitochondrial enzyme activity in amyotrophic lateral scler- osis: implications for the role of mitochondria neuronal cell death. Ann Neurol 1999; 46: 787–790.
   PubMed Web of Science ®Google Scholar
• Morrison BM, Janssen WGM, Gordon JW, Morrison JH. Light and electron microscopic distribution of the AMPA receptor subunit, Glu R2, in the spinal cord of control and G68R mutant superoxide dismutase transgenic mice. J Comp Neurol 1998; 395: 523–534.
   PubMed Web of Science ®Google Scholar
• Celio MR, Baier W, Scharer L, de Viragh PA, Gerday C. Mono- clonal antibodies directed against the calcium-binding protein parvalbumin. Cell Calcium 1988; 9: 81–86.
   Google Scholar
• Celio MR, Baier W, Scharer L, Gregersen HJ, de Viragh PA, Norman AW. Monoclonal antibodies directed against the calcium-binding protein calbindin-D28K. Cell Calcium 1990; 11: 599–602.
   Google Scholar
• Alexianu ME, Ho B-K, Mohamed AH, La Bella V, Smith RG, Appel SH. The role of calcium-binding proteins in selective motor neuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol 1994; 36: 846–858.
   PubMed Web of Science ®Google Scholar
• Ho B-K, Alexianu ME, Colom LV, Mohamed AH, Serrano F, Appel SH. Expression of calbindin-D28K in motoneuron- hybrid cells following retroviral infection with calbindin-D28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity. Proc Natl Acad Sci USA 1996; 93: 6796–6801.
   Google Scholar
• Roy J, Minotti S, Dong L, Figlewicz DA, Durham HD. Gluta- mate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-depen- dent mechanisms. J Neurosci 1998; 18: 9673–9684.
   PubMed Web of Science ®Google Scholar
• Lledo P-M, Somasundaram B, Morton AJ, Emson PC, Mason WT. Stable transfection of calbindin-D28K into GH3 cell line alters calcium currents and intracellular calcium in homeosta- sis. Neuron 1992; 9: 943–954.
   Google Scholar
• Appel SH. Excitotoxic neuronal cell death in amyotrophic lateral sclerosis. Trends Neurosci 1993; 16: 3–4.
   Google Scholar
• DeViragh PA, Haglid KG, Celio MR. Parvalbumin increases in the putamen of rats with vitamin D hypervitaminosis. Proc Natl Acad Sci USA 1989; 86: 3887–3890.
   Google Scholar
• Alexianu ME, Robbins E, Carswell S, Appel SH. 1 a, 25 dihy- droxyvitamin D3-dependent up-regulation of calcium- binding proteins in motoneuron cells. J Neurosci Res 1998; 51: 58–66.
   PubMed Web of Science ®Google Scholar
• Stumpf WE, O’Brien LP. 1,25 (OH)2-dilhydroxyvitamin D3 sites of action in the brain. Histochem 1994; 87: 393–406.
   Google Scholar
• Clemens TL, Garrett KP, Zhou X-Y, Pike Jw, Haussler MR, Dempster DW. Immunocytochemical localization of the 1,25-dilhydroxyvitamin D3 receptor in target cells. Endocrinology 1988; 122: 1224–1230.
   PubMedGoogle Scholar
• Norman AW, Nemere I, Zhou L-X, et al. 1,25 (OH)2-dilhy- droxyvitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J. Steroid Biochem. Mol Biol 1992; 41: 231–240.
   PubMed Web of Science ®Google Scholar
• Iacopino AM, Christakos S, Modi P, Altar CA. Nerve growth factor increases calcium binding protein (Calbindin-D28K) in rat olfactory bulb. Brain Res 1992; 578: 305–310.
   Google Scholar
• Yamaguchi T, Keino K, Fukuda J. The effect of insulin-like growth factor-1 on the expression of calretinin and calbindin D-28K in rat embryonic neurons in culture. Neurochem.Int 1995; 26: 255–262.
   Google Scholar
• Minghetti PP, Norman AW. 1,25 (OH)2-dilhydroxyvitamin D3 receptors: Gene regulation and genetic circuitry. FASEB J 1988; 2: 3043–3053.
   Google Scholar
• Tornquist K, Tashjian AH, Jr. Dual actions of 1,25-dilhydrox- ycholecalciferol on intracellular Ca2+ in GH C cells: Evidence for effects on voltage-operated Ca2+ channels and Na+/Ca2+ channels and Na+/Ca2+ exchange. Endocrinology 1989; 123: 2765–2776.
   Google Scholar
• Nataf S, Garcio E, Darcy F, Chabannes D, Muller JY, Brachet P. 1,25 dilhydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyellitis. J Neuropathol Exp Neurol 1996; 55: 904–914.
   PubMed Web of Science ®Google Scholar
• Garcion E, Thanh XD, Bled F, et al. 1,25-dilhydroxyvitamin D3 regulates g-glutamyl transpeptidase activity in rat brain. Neurosci Lett 1996; 216: 183–186.
   PubMed Web of Science ®Google Scholar
• Bouillon R, Okamura WH, Norman AW. Structure-function relationships in the vitamin D endocrine system. Endocr Rev 1995; 16: 200–257.
   PubMed Web of Science ®Google Scholar
• Hansen CM, Maenpaa PH. EB 1089, a novel vitamin D analog with strong antiproliferative and differentiation- inducing effects on target cells. Biochem Pharmacol 1997; 54: 1173–1179.
   PubMed Web of Science ®Google Scholar